VERV Stock Summary and Trading Ideas (Verve Therapeutics | NASDAQ:VERV)

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Verve Therapeutics trades on the NASDAQ stock market under the symbol VERV.

As of February 7, 2025, VERV stock price declined to $8.19 with 343,462 million shares trading.

VERV has a beta of 2.82, meaning it tends to be more sensitive to market movements. VERV has a correlation of 0.14 to the broad based SPY ETF.

VERV has a market cap of $693.07 million. This is considered a Small Cap stock.

Last quarter Verve Therapeutics reported $7 million in Revenue and -$.59 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.11.

In the last 3 years, VERV traded as high as $43.00 and as low as $4.31.

The top ETF exchange traded funds that VERV belongs to (by Net Assets): IWM, VTI, XBI, VXF, IWN.

VERV has underperformed the market in the last year with a return of -28.5%, while SPY returned +23.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VERV shares. However, VERV has outperformed the market in the last 3 month and 2 week periods, returning +27.8% and +2.5%, while SPY returned +2.0% and -1.5%, respectively. This indicates VERV has been having a stronger performance recently.

VERV support price is $7.82 and resistance is $8.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VERV shares will trade within this expected range on the day.